Barbara Schrörs

5.5k total citations · 2 hit papers
23 papers, 1.7k citations indexed

About

Barbara Schrörs is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Barbara Schrörs has authored 23 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 13 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Barbara Schrörs's work include Immunotherapy and Immune Responses (15 papers), Cancer Immunotherapy and Biomarkers (11 papers) and vaccines and immunoinformatics approaches (9 papers). Barbara Schrörs is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), Cancer Immunotherapy and Biomarkers (11 papers) and vaccines and immunoinformatics approaches (9 papers). Barbara Schrörs collaborates with scholars based in Germany, United Kingdom and United States. Barbara Schrörs's co-authors include Martin Löwer, Uğur Şahin, Özlem Türeci, Mathias Vormehr, Arbel D. Tadmor, Sebastian Boegel, Franziska Lang, Mustafa Diken, Fulvia Vascotto and Sebastian Kreiter and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and Nature Biotechnology.

In The Last Decade

Barbara Schrörs

22 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mutant MHC class II epitopes drive therapeutic immune responses to cancer

2015 915 citations Sebastian Kreiter, Mathias Vormehr et al. Nature profile →
Identification of neoantigens for individualized therapeutic cancer vaccines

2022 330 citations Franziska Lang, Barbara Schrörs et al. Nature Reviews Drug Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara Schrörs Germany	12	1.2k	1.0k	783	175	163	23	1.7k
Mathias Vormehr Germany	13	1.2k 1.0×	990 1.0×	850 1.1×	143 0.8×	153 0.9×	23	1.8k
Iñaki Etxeberría Spain	17	1.1k 0.9×	1.1k 1.0×	616 0.8×	106 0.6×	222 1.4×	25	1.9k
Niels van de Roemer Germany	3	1.3k 1.0×	1.0k 1.0×	597 0.8×	167 1.0×	90 0.6×	7	1.5k
Sebastian Boegel Germany	13	1.8k 1.5×	1.5k 1.5×	1.1k 1.3×	282 1.6×	167 1.0×	24	2.5k
Sander Kelderman Netherlands	10	1.2k 1.0×	1.4k 1.4×	526 0.7×	113 0.6×	295 1.8×	12	2.0k
Sara Bobisse Switzerland	19	667 0.5×	1000 1.0×	1.1k 1.4×	211 1.2×	83 0.5×	31	1.8k
Tetsuro Sasada Japan	18	1.2k 1.0×	800 0.8×	434 0.6×	100 0.6×	117 0.7×	49	1.7k
Norma Bloy France	19	841 0.7×	776 0.8×	483 0.6×	87 0.5×	63 0.4×	39	1.5k
Inja Waldhauer Switzerland	10	1.6k 1.3×	852 0.8×	741 0.9×	578 3.3×	111 0.7×	22	2.3k
Kalijn F. Bol Netherlands	21	1.3k 1.1×	1.1k 1.1×	523 0.7×	62 0.4×	118 0.7×	42	1.7k

Countries citing papers authored by Barbara Schrörs

Since Specialization

Citations

This map shows the geographic impact of Barbara Schrörs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Schrörs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Schrörs more than expected).

Fields of papers citing papers by Barbara Schrörs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Schrörs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Schrörs. The network helps show where Barbara Schrörs may publish in the future.

Co-authorship network of co-authors of Barbara Schrörs

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Schrörs. A scholar is included among the top collaborators of Barbara Schrörs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Schrörs. Barbara Schrörs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fuchs, Alexander, Michael Fichter, Pia Winterwerber, et al.. (2026). Biodegradable Carbonate Nanogels Loaded with Anti MFAP‐5 siRNA for Anti‐stromal Therapy of Hepatocellular Carcinoma. Advanced Science. e10006–e10006.

Schneider, Paul M., Michael Fichter, Federica De Lorenzi, et al.. (2024). A hepatocellular carcinoma model with and without parenchymal liver damage that integrates technical and pathophysiological advantages for therapy testing. Pharmacological Research. 211. 107560–107560. 2 indexed citations

Lang, Franziska, Patrick Sorn, M Suchan, et al.. (2024). Prediction of tumor-specific splicing from somatic mutations as a source of neoantigen candidates. Bioinformatics Advances. 4(1). vbae080–vbae080. 2 indexed citations

Weber, David, Martin Löwer, Valesca Bukur, et al.. (2024). Temporal evolution and inter-patient heterogeneity in primary and recurrent head and neck squamous cell carcinoma. SHILAP Revista de lepidopterología. 2(1). 62–62. 1 indexed citations

Lang, Franziska, Barbara Schrörs, Martin Löwer, Özlem Türeci, & Uğur Şahin. (2023). Author Correction: Identification of neoantigens for individualized therapeutic cancer vaccines. Nature Reviews Drug Discovery. 23(2). 156–156. 4 indexed citations

Bukur, Thomas, Pablo Riesgo-Ferreiro, Patrick Sorn, et al.. (2023). CoVigator—A Knowledge Base for Navigating SARS-CoV-2 Genomic Variants. Viruses. 15(6). 1391–1391. 2 indexed citations

Schrörs, Barbara, Martin Löwer, Franziska Lang, et al.. (2023). MC38 colorectal tumor cell lines from two different sources display substantial differences in transcriptome, mutanome and neoantigen expression. Frontiers in Immunology. 14. 1102282–1102282. 9 indexed citations

Lang, Franziska, Patrick Sorn, Barbara Schrörs, et al.. (2023). Multiple instance learning to predict immune checkpoint blockade efficacy using neoantigen candidates. iScience. 26(11). 108014–108014. 1 indexed citations

Salomon, Nadja, Alexander Helm, Abderaouf Selmi, et al.. (2023). Carbon Ion and Photon Radiation Therapy Show Enhanced Antitumoral Therapeutic Efficacy With Neoantigen RNA-LPX Vaccines in Preclinical Colon Carcinoma Models. International Journal of Radiation Oncology*Biology*Physics. 119(3). 936–945. 1 indexed citations

10.

Weber, David, Jonas Ibn-Salem, Patrick Sorn, et al.. (2022). Accurate detection of tumor-specific gene fusions reveals strongly immunogenic personal neo-antigens. Nature Biotechnology. 40(8). 1276–1284. 34 indexed citations

11.

Lang, Franziska, Barbara Schrörs, Martin Löwer, Özlem Türeci, & Uğur Şahin. (2022). Identification of neoantigens for individualized therapeutic cancer vaccines. Nature Reviews Drug Discovery. 21(4). 261–282. 330 indexed citations breakdown →

12.

Weber, David, Martin Löwer, Valesca Bukur, et al.. (2021). Comprehensive Genomic and Transcriptomic Analysis of Three Synchronous Primary Tumours and a Recurrence from a Head and Neck Cancer Patient. International Journal of Molecular Sciences. 22(14). 7583–7583. 3 indexed citations

13.

Lang, Franziska, Pablo Riesgo-Ferreiro, Martin Löwer, Uğur Şahin, & Barbara Schrörs. (2021). NeoFox: annotating neoantigen candidates with neoantigen features. Bioinformatics. 37(22). 4246–4247. 10 indexed citations

14.

Schrörs, Barbara, Pablo Riesgo-Ferreiro, Patrick Sorn, et al.. (2021). Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates. PLoS ONE. 16(9). e0249254–e0249254. 26 indexed citations

15.

Schrörs, Barbara, Sebastian Boegel, Christian Albrecht, et al.. (2020). Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor Model. Frontiers in Oncology. 10. 1195–1195. 141 indexed citations

16.

Schrörs, Barbara, et al.. (2020). Bioinformatics for Cancer Immunotherapy. Methods in molecular biology. 2120. 1–9. 42 indexed citations

17.

Türeci, Özlem, Martin Löwer, Barbara Schrörs, et al.. (2018). Challenges towards the realization of individualized cancer vaccines. Nature Biomedical Engineering. 2(8). 566–569. 38 indexed citations

18.

Schrörs, Barbara, Volker Lennerz, Martina Fatho, et al.. (2017). HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model. Oncotarget. 8(17). 28312–28327. 25 indexed citations

19.

Zhao, Fang, Antje Sucker, Susanne Horn, et al.. (2016). Melanoma Lesions Independently Acquire T-cell Resistance during Metastatic Latency. Cancer Research. 76(15). 4347–4358. 57 indexed citations

20.

Kreiter, Sebastian, Mathias Vormehr, Niels van de Roemer, et al.. (2015). Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature. 520(7549). 692–696. 915 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact